Cargando…
Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support – a case report
BACKGROUND: Coronavirus disease 2019 (COVID-19) spreading from Wuhan, Hubei province in China, is an expanding global pandemic with significant morbidity and mortality. Even though respiratory failure is the cardinal form of severe COVID-19, concomitant cardiac involvement is common. Myocarditis is...
Autores principales: | Papageorgiou, Joanna-Maria, Almroth, Henrik, Törnudd, Mattias, van der Wal, Henriëtte, Varelogianni, Georgia, Lawesson, Sofia Sederholm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799209/ https://www.ncbi.nlm.nih.gov/pubmed/33594347 http://dx.doi.org/10.1093/ehjcr/ytaa523 |
Ejemplares similares
-
Mechanical Circulatory Support as a Bridge to Recovery in Fulminant Myocarditis
por: Iqbal, Yassir, et al.
Publicado: (2015) -
Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021) -
COVID-19 “Fulminant Myocarditis” Successfully Treated With Temporary Mechanical Circulatory Support
por: Salamanca, Jorge, et al.
Publicado: (2020) -
Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support
por: Nakashima, Hiroshi, et al.
Publicado: (2013) -
A case of COVID‐19‐associated fulminant myocarditis successfully treated with mechanical circulatory support
por: Asakura, Ryosuke, et al.
Publicado: (2022)